Status: Recruiting
Optical Genome Mapping in Hematological Malignancies
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
Participants needed: 200
Trial details
Biological sex: AllType: ObservationalSponsor: University Hospital, BrestUpdated: Aug 17, 2021Locations: 4
Eligibility criteria
Minor/Major Patients [+2]
Patients under judicial protection (guardianship, curatorship, ...), [+1]